HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-sta

Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market s

Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook art

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may pr

MARKER THERAPEUTICS (MRKR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism a

MARKER THERAPEUTICS, INC. (MRKR) came out with a quarterly loss of $0.04 per share versus the Zacks

Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response

HOUSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stag

Marker Therapeutics' shares jump 114% in three months as early MT-601 data showed strong responses,

After reaching an important support level, MARKER THERAPEUTICS, INC. (MRKR) could be a good stock pi

Innovation is at its peak in the Zacks Medical-Drugs industry. SLNO, NKTR, RIGL, IRWD and MRKR may p

Clinical study from Baylor College of Medicine demonstrates a favorable safety profile and up to 84.

APOLLO study showed encouraging overall responses and favorable safety profile in relapsed/refractor

HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stag

Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphomas showed

Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T c

HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stag

Marker Therapeutics, Inc. MRKR on Tuesday provided an update on the progress and clinical observatio

Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphoma showed 6

HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stag

HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stag

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company cease

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average vo

  On Friday, 93 stocks made new 52-week lows.

  On Thursday, 175 stocks hit new 52-week lows.

  During Wednesday's session, 104 stocks hit new 52-week lows.

  On Monday, 198 companies hit new 52-week lows.

  On Friday, 497 companies set new 52-week lows.

  On Thursday, 116 companies set new 52-week lows.

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% o

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares jumped 52% to $2.1325 after B of A Securiti

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after

Gainers

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday

  Monday's session saw 84 companies set new 52-week lows.

  During Friday's trading, 69 companies set new 52-week lows.

Gainers

  On Friday, 213 companies hit new 52-week lows.

    On Monday, 721 companies achieved new lows for the year.

    During Tuesday's trading, 505 companies set new 52-week lows.

    On Friday, 313 companies hit new 52-week lows.

    On Thursday, 147 companies achieved new lows for the year.

  Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday afte

  During Friday's session, 445 companies made new 52-week lows.